{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:02:13Z","timestamp":1770822133447,"version":"3.50.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.jaci.2010.01.055","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T05:02:06Z","timestamp":1271307726000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract"],"prefix":"10.1016","volume":"126","author":[{"given":"Dagmar","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wardlaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2010.01.055_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.24.021605.090720","article-title":"The eosinophil","volume":"24","author":"Rothenberg","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2010.02.026","article-title":"What targeting the eosinophil has taught us about their role in diseases","volume":"126","author":"Bochner","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jaci.2007.02.010","article-title":"Eosinophilic disorders","volume":"119","author":"Simon","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000236651","article-title":"Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals","volume":"103","author":"Kagi","year":"1994","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1523-1747.1999.00720.x","article-title":"T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis","volume":"113","author":"Akdis","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1346-8138.1999.tb02064.x","article-title":"Eosinophil activation and in situ interleukin-5 production by mononuclear cells in skin lesions of patients with drug hypersensitivity","volume":"26","author":"Mikami","year":"1999","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mai.2002.123236","article-title":"TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction","volume":"109","author":"Ying","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood.V79.3.688.688","article-title":"Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia","volume":"79","author":"Butterfield","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2010.01.055_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1365-2133.1999.02907.x","article-title":"Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris","volume":"140","author":"Rico","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib11","first-page":"75","article-title":"Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis","volume":"28","author":"Viallard","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00015550152384191","article-title":"Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis","volume":"81","author":"Amerio","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2010.01.055_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib14","first-page":"918","article-title":"Wells' syndrome: a pathogenic role for circulating CD4+CD7- T cells expressing interleukin-5 mRNA","volume":"136","author":"Yagi","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000053723","article-title":"Clinical and immunological features of patients with interleukin-5-producing T cell clones and eosinophilia","volume":"124","author":"Simon","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib16","first-page":"897","article-title":"Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins","volume":"148","author":"Borrego","year":"1996","journal-title":"Am J\u00a0Pathol"},{"issue":"suppl","key":"10.1016\/j.jaci.2010.01.055_bib17","first-page":"S37","article-title":"The role of cytokines in the pathogenesis of Langerhans cell histiocytosis","volume":"23","author":"Kannourakis","year":"1994","journal-title":"Br J Cancer Suppl"},{"key":"10.1016\/j.jaci.2010.01.055_bib18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4049\/jimmunol.150.3.1084","article-title":"Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites","volume":"150","author":"Massey","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1523-1747.1999.00619.x","article-title":"Enhanced expression of eotaxin and CCR3 in atopic dermatitis","volume":"113","author":"Yawalkar","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","article-title":"Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions","volume":"106","author":"Yawalkar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1046\/j.1365-2133.2000.03765.x","article-title":"Expression of eotaxin, interleukin 13 and tumour necrosis factor-alpha in dermatitis herpetiformis","volume":"143","author":"Amerio","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/315041","article-title":"Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine","volume":"180","author":"Pearlman","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2010.01.055_bib23","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V94.6.2065","article-title":"Hodgkin\/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils","volume":"94","author":"Jundt","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2010.01.055_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-4362.2003.01705.x","article-title":"Wells' syndrome: a clinical and histopathologic review of seven cases","volume":"42","author":"Moossavi","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib26","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1056\/NEJMoa031261","article-title":"Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis","volume":"349","author":"Plotz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia","volume":"341","author":"Simon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jaad.2006.02.034","article-title":"Eosinophilic pustular folliculitis: a 40 year retrospect","volume":"55","author":"Nervi","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jcp.2008.058289","article-title":"Drug-induced cutaneous pathology","volume":"62","author":"Ramdial","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2010.01.055_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaci.2010.01.055_bib31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1365-2133.2001.04456.x","article-title":"Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining","volume":"145","author":"Kiehl","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.1992.tb00677.x","article-title":"Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis","volume":"126","author":"Czech","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1056\/NEJM198508013130502","article-title":"Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis","volume":"313","author":"Leiferman","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-6749(97)70031-9","article-title":"Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration","volume":"99","author":"Cheng","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2010.01.055_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2133.2000.03599.x","article-title":"Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia","volume":"143","author":"Wakugawa","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaad.2006.06.010","article-title":"Aggressive histiocytic disorders that can involve the skin","volume":"56","author":"Newman","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaad.2004.03.003","article-title":"In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia","volume":"52","author":"Ionescu","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0952-7915(94)90005-1","article-title":"The role of eosinophils in the pathogenesis of asthma","volume":"6","author":"Seminario","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/137.1.62","article-title":"Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity","volume":"137","author":"Wardlaw","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2010.01.055_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-065X.2001.790117.x","article-title":"Elemental signals regulating eosinophil accumulation in the lung","volume":"179","author":"Foster","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2010.01.055_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1067\/mai.2003.169","article-title":"The role of T lymphocytes in the pathogenesis of asthma","volume":"111","author":"Larche","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib44","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0091-6749(99)70069-2","article-title":"Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm","volume":"104","author":"Wardlaw","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib45","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(89)92801-8","article-title":"Chronic cough: eosinophilic bronchitis without asthma","volume":"1","author":"Gibson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2010.01.055_bib46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm.160.2.9810100","article-title":"Eosinophilic bronchitis is an important cause of chronic cough","volume":"160","author":"Brightling","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib47","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.073429","article-title":"Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma","volume":"62","author":"Berry","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2010.01.055_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mai.2001.116576","article-title":"Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys","volume":"108","author":"Hart","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1067\/mai.2001.119149","article-title":"The trials and tribulations of IL-5, eosinophils, and allergic asthma","volume":"108","author":"O'Byrne","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2004.10.036","article-title":"Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa","volume":"115","author":"Fukakusa","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib52","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.4049\/jimmunol.180.12.8354","article-title":"CCL11 and GM-CSF differentially use the Rho GTPase pathway to regulate motility of human eosinophils in a three-dimensional microenvironment","volume":"180","author":"Muessel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib53","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/thorax.58.2.98","article-title":"The new BTS\/SIGN asthma guidelines: where evidence leads the way","volume":"58","author":"Higgins","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2010.01.055_bib55","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1365-2222.2009.03321.x","article-title":"The definition and diagnosis of asthma","volume":"39","author":"Hargreave","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2010.01.055_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2222.2009.03410.x","article-title":"The A to E of the airway disease","volume":"40","author":"Pavord","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2010.01.055_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(82)91152-7","article-title":"Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma","volume":"2","author":"Filley","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2010.01.055_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.53.2.91","article-title":"Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma","volume":"53","author":"Jatakanon","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2010.01.055_bib59","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2010.01.055_bib60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1183\/09031936.06.00137704","article-title":"Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations","volume":"27","author":"Jayaram","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2010.01.055_bib61","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib62","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib63","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2222.2008.03157.x","article-title":"Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype","volume":"39","author":"Dougherty","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2010.01.055_bib65","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1378\/chest.130.4.1203","article-title":"How viral infections cause exacerbation of airway diseases","volume":"130","author":"Mallia","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2010.01.055_bib66","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib67","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1398-9995.2005.00887.x","article-title":"Allergic bronchopulmonary aspergillosis","volume":"60","author":"Tillie-Leblond","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2010.01.055_bib68","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1365-2222.2009.03339.x","article-title":"Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma","volume":"39","author":"O'Driscoll","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2010.01.055_bib69","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mai.2003.1388","article-title":"Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial","volume":"111","author":"Wark","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib70","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.200805-737OC","article-title":"Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study","volume":"179","author":"Denning","year":"2009","journal-title":"Am J\u00a0Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib72","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.iac.2007.07.005","article-title":"Pulmonary eosinophilic syndromes","volume":"27","author":"Wechsler","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2010.01.055_bib73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2010.01.055_bib74","doi-asserted-by":"crossref","first-page":"L93","DOI":"10.1152\/ajplung.1997.273.1.L93","article-title":"Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function","volume":"273","author":"Costello","year":"1997","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"suppl","key":"10.1016\/j.jaci.2010.01.055_bib75","first-page":"S69","article-title":"Update on the pathogenesis of Churg-Strauss syndrome","volume":"21","author":"Hellmich","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib76","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/thx.2007.093955","article-title":"Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective","volume":"63","author":"Nathani","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2010.01.055_bib77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2006-939515","article-title":"Eosinophilic airway disorders","volume":"27","author":"Scott","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib78","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2010.01.055_bib79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2006-939520","article-title":"Parasitic pulmonary eosinophilia","volume":"27","author":"Chitkara","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib80","first-page":"122","article-title":"Pulmonary manifestations of strongyloidiasis","volume":"12","author":"Wehner","year":"1997","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.jaci.2010.01.055_bib81","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","article-title":"Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment","volume":"133","author":"Furuta","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2010.01.055_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaci.2003.10.047","article-title":"Eosinophilic gastrointestinal disorders (EGID)","volume":"113","author":"Rothenberg","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib83","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2350\/11-05-0130.1","article-title":"Quantity and distribution of eosinophils in the gastrointestinal tract of children","volume":"9","author":"Debrosse","year":"2006","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jaci.2010.01.055_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.giec.2007.09.014","article-title":"Histopathologic features of eosinophilic esophagitis","volume":"18","author":"Collins","year":"2008","journal-title":"Gastrointest Endosc Clin North Am"},{"key":"10.1016\/j.jaci.2010.01.055_bib85","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1067\/mai.2001.120095","article-title":"Pathogenesis and clinical features of eosinophilic esophagitis","volume":"108","author":"Rothenberg","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib86","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaci.2006.07.038","article-title":"Eosinophilic esophagitis: pathogenesis, genetics, and therapy","volume":"118","author":"Blanchard","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib87","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM200408263510924","article-title":"Eosinophilic esophagitis","volume":"351","author":"Noel","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2010.01.055_bib88","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/j.gastro.2009.07.007","article-title":"Biology and treatment of eosinophilic esophagitis","volume":"137","author":"Rothenberg","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2010.01.055_bib89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI10224","article-title":"An etiological role for aeroallergens and eosinophils in experimental esophagitis","volume":"107","author":"Mishra","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2010.01.055_bib90","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.gastro.2003.07.007","article-title":"Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism","volume":"125","author":"Mishra","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2010.01.055_bib91","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0091-6749(03)01715-9","article-title":"Pollen and eosinophilic esophagitis","volume":"112","author":"Fogg","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.giec.2007.09.001","article-title":"Eosinophilic esophagitis: association with allergic disorders","volume":"18","author":"Assa'ad","year":"2008","journal-title":"Gastrointest Endosc Clin North Am"},{"key":"10.1016\/j.jaci.2010.01.055_bib93","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaci.2006.10.044","article-title":"Pediatric patients with eosinophilic esophagitis: an 8-year follow-up","volume":"119","author":"Assa'ad","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib94","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1067\/mai.2001.119917","article-title":"Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response","volume":"108","author":"Straumann","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib95","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.giec.2007.09.016","article-title":"Basic pathogenesis of eosinophilic esophagitis","volume":"18","author":"Blanchard","year":"2008","journal-title":"Gastrointest Endosc Clin North Am"},{"key":"10.1016\/j.jaci.2010.01.055_bib96","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/j.gastro.2005.06.027","article-title":"Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice","volume":"129","author":"Akei","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2010.01.055_bib97","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.168.5.2464","article-title":"Interleukin-5 promotes eosinophil trafficking to the esophagus","volume":"168","author":"Mishra","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib98","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI26679","article-title":"Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis","volume":"116","author":"Blanchard","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2010.01.055_bib99","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.humpath.2007.05.008","article-title":"Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease","volume":"38","author":"Bhattacharya","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaci.2010.01.055_bib100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jaci.2007.10.024","article-title":"IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibilty with glucocorticoids","volume":"120","author":"Blanchard","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib101","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S1542-3565(05)00885-2","article-title":"Eosinophilic esophagitis: a 10-year experience in 381 children","volume":"3","author":"Liacouras","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2010.01.055_bib102","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1572-0241.2007.01379.x","article-title":"Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children","volume":"102","author":"Aceves","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2010.01.055_bib103","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2006.08.033","article-title":"A randomized double-blind-placebo controlled trial of fluticasone proprionate for pediatric eosinophilic esophagitis","volume":"131","author":"Konikoff","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2010.01.055_bib104","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1365-2222.2005.02299.x","article-title":"Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354)","volume":"35","author":"Blanchard","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2010.01.055_bib105","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2010.01.055_bib107","first-page":"215","article-title":"Eosinophilic gastroenteritis","volume":"2","author":"Klein","year":"1970","journal-title":"Medicine"},{"key":"10.1016\/j.jaci.2010.01.055_bib108","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01540983","article-title":"Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma interferon in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis","volume":"14","author":"Jaffe","year":"1994","journal-title":"J Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2010.01.055_bib109","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/00005176-200001001-00009","article-title":"Food-induced eosinophilic proctocolitis","volume":"30","author":"Lake","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2010.01.055_bib110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1067\/mai.2002.122503","article-title":"Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile","volume":"109","author":"Beyer","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.01.055_bib111","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.mpg.0000221903.61157.4e","article-title":"Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up","volume":"42","author":"Chehade","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2010.01.055_bib112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-230X-5-24","article-title":"Eosinophilic gastroenteritis in a young girl\u2014long term remission under montelukast","volume":"5","author":"Quack","year":"2005","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaci.2010.01.055_bib113","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11882-005-0062-4","article-title":"Clinical management of eosinophilic gastrointestinal disorders","volume":"5","author":"Foroughi","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2010.01.055_bib114","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(95)92782-4","article-title":"Eosinophilic colitis associated with larvae of the pinworm Enterobius vermicularis","volume":"346","author":"Liu","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2010.01.055_bib115","first-page":"387","article-title":"Colon mucosal pathology in infants under three months of age with diarrhea disorders","volume":"35","author":"Chang","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2010.01.055_bib116","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/0016-5085(85)90019-8","article-title":"Milk- and soy protein-induced enterocolitis: evidence for lymphocyte sensitization to specific food proteins","volume":"88","author":"Van Sickle","year":"1985","journal-title":"Gastroenterology"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674910002861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674910002861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:21:41Z","timestamp":1758788501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674910002861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0091674910002861"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2010.01.055","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2010.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}